Atlas Trials

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Clinical trial NCT03716700 · COMPLETED

Trial details

NCT number
NCT03716700
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Study type
OBSERVATIONAL
Primary Immunodeficiency Diseases (PID)
Start date
2018-09-24
Primary completion
2020-07-23
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.